Feline atopic dermatitis is the inflammation of the skin seen in the cats. Feline atopic dermatitis is often triggered by causative allergens which are either inhaled or through skin contact leading to inflammation of the skin. As per the study carried out by the Canadian Veterinary Journal the conservative prevalence of the feline atopic dermatitis in the cats is around 12.5% whereas the actual prevalence is high as it is very common disorder in cats. The diagnosis of the often starts when itchy skin is observed in the cats. The feline atopic dermatitis treatment often involves the medications which help to decrease the immune response which causes pruritus. Various non-inflammatory drugs are also used in the feline atopic dermatitis treatment. Most often the feline atopic dermatitis is lifelong condition of inflamed skin, it may be seasonal or non-seasonal which leads to frequent visits to veterinarians for feline atopic dermatitis treatment.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9572
Feline Atopic Dermatitis Treatment Market: Drivers and Restraints
High prevalence of atopic dermatitis among the cats irrespective of the region expected to drive the growth of the feline atopic dermatitis treatment market. Around 62.0% of U.S. households have one or more companion animals and it is expected to increase rapidly which in turn expected to drive the growth of the feline atopic dermatitis treatment market.
Increasing trend of companion animals in regions such as Asia-Pacific and Latin America further expected to fuel the growth of the feline atopic dermatitis treatment market. Increasing diagnosis and subsequently increasing treatment seeking rate for various diseases in companion animals further expected to drive the growth of the feline atopic dermatitis treatment market. Increasing number of companion animals coupled with increasing number of veterinarians in the developing countries expected to drive the growth of the feline atopic dermatitis treatment market. Whereas, lack of novel treatment which can prevent the reoccurrence of the atopic dermatitis may hamper the growth of the feline atopic dermatitis treatment market.
Feline Atopic Dermatitis Treatment Market: Overview
The global feline atopic dermatitis treatment market is expected to experience significant growth due to increasing prevalence of the feline atopic dermatitis. By drug class, corticosteroids is expected to dominate the global feline atopic dermatitis treatment market by revenue due to higher efficacy as compared to other drug classes. By route of administration, feline atopic dermatitis treatment market is expected to be dominated by topical segment due to higher compliance. By distribution channel, feline atopic dermatitis treatment market is expected to be dominated by veterinary pharmacies due to higher footfall.
Feline Atopic Dermatitis Treatment Market: Regional Outlook
North America expected to dominate the global feline atopic dermatitis treatment market due to higher number of companion animals in the region. Europe feline atopic dermatitis treatment market due to increasing number of companion animals as well as higher treatment seeking rate as compared to other developing regions. Asia-Pacific is emerging feline atopic dermatitis treatment market due to rapidly increasing companion animal ownership and emerging countries such as India and China. Latin America is expected to experience gradual growth in the feline atopic dermatitis treatment market due to increasing product availability in the region. Middle East & Africa feline atopic dermatitis treatment market is expected to be least lucrative market due to least adoption of feline atopic dermatitis treatment.
Feline Atopic Dermatitis Treatment Market: Key Players
The key market players operating in the feline atopic dermatitis treatment market are: Bausch Health Companies Inc., Bayer AG, Pfizer Inc., Novartis AG, Eli Lily Company, Sanofi, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH and others.
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9572
Why Future Market Insights?
• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com